Belarus vs Chile: Death rate from Alzheimer's
Belarus
33.31 deaths per 100,000 people
in 2021
Chile
32.66 deaths per 100,000 people
in 2021
Belarus rank
42nd
Chile rank
44th
Death rate from Alzheimer's over time
- Belarus
- Chile
How they compare
Belarus currently reports 33.31 deaths per 100,000 people against 32.66 deaths per 100,000 people in Chile, a difference of 0.65 deaths per 100,000 people.
Across all 22 years both countries report, Belarus has been ahead every year.
Belarus ranks 42nd and Chile ranks 44th of 194 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25.36 deaths per 100,000 people | 18.08 deaths per 100,000 people | 7.28 deaths per 100,000 people | Belarus |
| 2010s | 33.48 deaths per 100,000 people | 21.5 deaths per 100,000 people | 11.98 deaths per 100,000 people | Belarus |
| 2020s | 33.64 deaths per 100,000 people | 28.34 deaths per 100,000 people | 5.31 deaths per 100,000 people | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Belarus or Chile?
- Belarus, at 33.31 deaths per 100,000 people against 32.66 deaths per 100,000 people in Chile as of 2021.
- What is the difference in death rate from alzheimer's between Belarus and Chile?
- 0.65 deaths per 100,000 people, with Belarus ahead.
- How many years of comparable data are there for Belarus and Chile?
- 22 years are reported by both, from 2000 to 2021.
- How do Belarus and Chile rank globally for death rate from alzheimer's?
- Belarus ranks 42nd and Chile ranks 44th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.